Clinical Trials Directory

Trials / Conditions / Optic Neuritis

Optic Neuritis

60 registered clinical trials studyying Optic Neuritis9 currently recruiting.

StatusTrialSponsorPhase
RecruitingEfgartigimod for the Treatment of Acute Optic Neuritis
NCT06453694
Anastasia Vishnevetsky, MD, MPHPhase 2
RecruitingTreatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
NCT07100990
Mayo ClinicPhase 3
Not Yet RecruitingEvaluation of Optic Neuritis Using Synthetic Quantitative MRI
NCT06916182
Fondation Ophtalmologique Adolphe de Rothschild
RecruitingLight Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple Sclerosis
NCT06389968
Technical University of MunichN/A
CompletedBuilding Research With Artificial Intelligence in Neuro-Ophthalmology
NCT06390579
Fondation Ophtalmologique Adolphe de Rothschild
RecruitingVIsual Pathways Model in Neuro-inflammatory Disorders
NCT05487989
University Hospital, Lille
UnknownFampridine-SR and Optic Neuritis Recovery
NCT04148781
Courtney CasserlyEARLY_Phase 1
RecruitingEdaravone in the Treatment of Optic Neuritis
NCT05540262
First Affiliated Hospital of Guangxi Medical UniversityN/A
UnknownRetrobulbar Methylprednisolone as Adjunctive Treatment in Optic Neuritis Trial
NCT04942002
Asociación para Evitar la Ceguera en MéxicoPhase 2 / Phase 3
CompletedOCS-05 in Patients With Optic Neuritis
NCT04762017
OculisPhase 2
CompletedIdentification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics
NCT04289909
Institut National de la Santé Et de la Recherche Médicale, FranceN/A
CompletedOptical Coherence Tomography and Optic Neuritis Not Related to Multiple Sclerosis
NCT03963310
Fondation Ophtalmologique Adolphe de Rothschild
UnknownAcute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Ac
NCT05605951
Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul
UnknownEpidemiologic and Clinical Characteristics of Optic Neuritis in China
NCT04257734
Chinese PLA General Hospital
RecruitingSwiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
NCT05017142
University of Bern
UnknownDiffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy.
NCT05353413
Medical University of BialystokN/A
TerminatedDiagnosis of ON With or Without MS or NMOSD
NCT04131764
Jagannadha R Avasarala
UnknownEffect of Transorbital Electrical STIMulation of Optic Nerve on Remyelination After an Acute Optic Neuritis
NCT04042363
Centre Hospitalier National d'Ophtalmologie des Quinze-VingtsN/A
UnknownOptic Neuritis Differential Diagnosis Study
NCT03370965
University Hospital Center of MartiniqueN/A
UnknownEffectiveness of Plasma Exchange in Treating With Severe Acute AQP4-Ab Positive Optic Neuritis
NCT03586557
Chinese PLA General HospitalN/A
CompletedBN201 SAD MAD Study in Healthy Subjects
NCT03630497
Accure TherapeuticsPhase 1
CompletedInitial Clinical Presentation of Inflammatory Optic Neuritis Associated or Not With Autoantibodies Anti-Myelin
NCT03345537
Nantes University Hospital
RecruitingRetinal Neuro-vascular Coupling in Patients With Multiple Sclerosis
NCT03401879
Medical University of ViennaN/A
CompletedThe Effect of a Gluten Free Diet on the Permeability of the Blood Brain Barrier in Patients With CIS
NCT03451955
University of CopenhagenN/A
CompletedPost-COntrast 3D SE T1 Versus Coronal SE T1-WI MRI in Detecting Optic Neuritis (COCON)
NCT04793087
Fondation Ophtalmologique Adolphe de Rothschild
Completed3D FLAIR Versus Coronal T2-WI MRI in Detecting Optic Neuritis (FLACON)
NCT04792866
Fondation Ophtalmologique Adolphe de Rothschild
CompletedCan Diffusion Tensor Imaging (DTI) of the Optic Ways Contributes to Predict the 6 Months Prognosis of Optic Ne
NCT03570385
Rennes University HospitalN/A
TerminatedHigh-Dose Vitamin D Induction in Optic Neuritis
NCT03302585
University of CalgaryPhase 2
CompletedEffect of Phenytoin on the Ganglion Cell Layer in Patients With Optic Neuritis
NCT02939937
Tehran University of Medical SciencesPhase 2
RecruitingAssessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
NCT02521311
University of California, San FranciscoPhase 2
TerminatedGypenosides Treatment for Optic Neuritis
NCT02976766
First Affiliated Hospital of Guangxi Medical UniversityPhase 2
CompletedOptic Neuritis and Ganglion Cell Layer
NCT02864134
CHU de Quebec-Universite Laval
CompletedPupillometry Dynamic Measures in Patients Without Ocular or Neurological Disease
NCT02894281
Fondation Ophtalmologique Adolphe de Rothschild
CompletedLinking Optic Nerve MRI and the Retinal Axonal Loss After Optic Neuritis
NCT03651362
University Hospital, Lille
CompletedTreatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial
NCT01962571
University Eye Hospital, FreiburgPhase 3
UnknownThe Correlation Between AQP-4 Ab and the Visual Function of Patients With Demyelinating ON at Onset
NCT02886377
Xiujuan Zhao
CompletedDefining the Functional and Neuro-Protective Potential of ACTHAR in Acute Optic Neuritis
NCT01987167
Neuro-Ophthalmologic Associates, PCEARLY_Phase 1
CompletedOcular Manifestations in Rheumatic Diseases
NCT03753893
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
CompletedAmiloride Clinical Trial In Optic Neuritis
NCT01802489
University of OxfordPhase 2
CompletedInterest of Dynamic Measures of the Pupil in Optic Neuritis
NCT02004054
Fondation Ophtalmologique Adolphe de Rothschild
CompletedOptical Coherence Tomography in Multiple Sclerosis Patients
NCT01774123
The Cleveland Clinic
Active Not RecruitingThe Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
NCT01623076
University of Texas Southwestern Medical Center
CompletedOptic Neuritis Recovery After Oral or IV Corticosteroids
NCT01524250
London Health Sciences CentrePhase 2 / Phase 3
CompletedNeuroprotection With Phenytoin in Optic Neuritis
NCT01451593
University College, LondonPhase 2
UnknownEffect of Vitamin D on Retinal Changes in Patient With Optic Neuritis by Optic Coherence Tomography
NCT01465893
Isfahan University of Medical SciencesPhase 2
CompletedAmpyra for Optic Neuritis in Multiple Sclerosis
NCT01337986
Washington University School of MedicinePhase 2 / Phase 3
CompletedLipoic Acid as a Treatment for Acute Optic Neuritis
NCT01294176
Oregon Health and Science UniversityPhase 1
CompletedVisual Reconstitution Therapy After Optic Neuritis
NCT01274702
Friedemann PaulPhase 2
TerminatedNeuroprotection and Repair in Optic Neuritis
NCT01073813
University of CalgaryPhase 2
CompletedA Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on
NCT00856635
Teva Branded Pharmaceutical Products R&D, Inc.Phase 3
TerminatedAtacicept in Subjects With Optic Neuritis
NCT00624468
EMD SeronoPhase 2
UnknownSimvastatin Treatment of Patients With Acute Optic Neuritis
NCT00261326
Glostrup University Hospital, CopenhagenPhase 3
CompletedSafety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuri
NCT00355095
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbHPhase 2
CompletedTLR-9 Antagonism in Steroid Resistant Optic Neuritis
NCT01424735
Sudhalkar Eye HospitalN/A
Active Not RecruitingBiobank For MS And Other Demyelinating Diseases
NCT00445367
Accelerated Cure Project for Multiple Sclerosis
WithdrawnInduction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to I
NCT00037115
MidAmerica Neuroscience Research Foundation at Rowe Neurology InstitutePhase 4
CompletedLong Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis
NCT00179478
Beth Israel Deaconess Medical CenterPhase 4
CompletedIntravenous Immunoglobulin Therapy in Optic Neuritis
NCT00000117
National Eye Institute (NEI)Phase 3
UnknownOptic Neuritis Treatment Trial (ONTT)
NCT00000146
National Eye Institute (NEI)Phase 3
UnknownLongitudinal Optic Neuritis Study (LONS)
NCT00000147
National Eye Institute (NEI)N/A